Rani Therapeutics Holdings, Inc. (RANI)
Nasdaq: RANI · CIK 0001856725 · United States
Every official Rani Therapeutics Holdings, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open RANI filings
Rani Therapeutics Holdings, Inc. documents
- Rani Therapeutics Holdings, Inc. 10-K 2026RANI 10-K 2026: annual report for fiscal 2026
- Rani Therapeutics Holdings, Inc. 10-K 2025RANI 10-K 2025: annual report for fiscal 2025
- Rani Therapeutics Holdings, Inc. 10-K 2024RANI 10-K 2024: annual report for fiscal 2024
- Rani Therapeutics Holdings, Inc. 10-K 2023RANI 10-K 2023: annual report for fiscal 2023
- Rani Therapeutics Holdings, Inc. 10-K 2022RANI 10-K 2022: annual report for fiscal 2022
- Rani Therapeutics Holdings, Inc. 10-Q 2026RANI 10-Q 2026: quarterly report for fiscal 2026
- Rani Therapeutics Holdings, Inc. 10-Q 2025RANI 10-Q 2025: quarterly report for fiscal 2025
- Rani Therapeutics Holdings, Inc. 10-Q 2024RANI 10-Q 2024: quarterly report for fiscal 2024
- Rani Therapeutics Holdings, Inc. 10-Q 2023RANI 10-Q 2023: quarterly report for fiscal 2023
- Rani Therapeutics Holdings, Inc. 10-Q 2022RANI 10-Q 2022: quarterly report for fiscal 2022
- Rani Therapeutics Holdings, Inc. 8-K 2026RANI 8-K 2026: current report for fiscal 2026
- Rani Therapeutics Holdings, Inc. 8-K 2025RANI 8-K 2025: current report for fiscal 2025
- Rani Therapeutics Holdings, Inc. 8-K 2024RANI 8-K 2024: current report for fiscal 2024
- Rani Therapeutics Holdings, Inc. 8-K 2023RANI 8-K 2023: current report for fiscal 2023
- Rani Therapeutics Holdings, Inc. 8-K 2022RANI 8-K 2022: current report for fiscal 2022
- Rani Therapeutics Holdings, Inc. DEF 14A 2026RANI DEF 14A 2026: proxy statement for fiscal 2026
- Rani Therapeutics Holdings, Inc. DEF 14A 2025RANI DEF 14A 2025: proxy statement for fiscal 2025
- Rani Therapeutics Holdings, Inc. DEF 14A 2024RANI DEF 14A 2024: proxy statement for fiscal 2024
- Rani Therapeutics Holdings, Inc. DEF 14A 2023RANI DEF 14A 2023: proxy statement for fiscal 2023
- Rani Therapeutics Holdings, Inc. DEF 14A 2022RANI DEF 14A 2022: proxy statement for fiscal 2022
- Rani Therapeutics Holdings, Inc. Form 4 2026RANI Form 4 2026: insider trading filing for fiscal 2026
- Rani Therapeutics Holdings, Inc. Form 4 2025RANI Form 4 2025: insider trading filing for fiscal 2025
- Rani Therapeutics Holdings, Inc. Form 4 2024RANI Form 4 2024: insider trading filing for fiscal 2024
- Rani Therapeutics Holdings, Inc. Form 4 2023RANI Form 4 2023: insider trading filing for fiscal 2023
- Rani Therapeutics Holdings, Inc. Form 4 2022RANI Form 4 2022: insider trading filing for fiscal 2022
- Rani Therapeutics Holdings, Inc. S-1 2026RANI S-1 2026: registration statement for fiscal 2026
- Rani Therapeutics Holdings, Inc. S-1 2025RANI S-1 2025: registration statement for fiscal 2025
- Rani Therapeutics Holdings, Inc. S-1 2024RANI S-1 2024: registration statement for fiscal 2024
- Rani Therapeutics Holdings, Inc. S-1 2023RANI S-1 2023: registration statement for fiscal 2023
- Rani Therapeutics Holdings, Inc. S-1 2022RANI S-1 2022: registration statement for fiscal 2022
- Rani Therapeutics Holdings, Inc. 13F 2026RANI 13F 2026: institutional holdings for fiscal 2026
- Rani Therapeutics Holdings, Inc. 13F 2025RANI 13F 2025: institutional holdings for fiscal 2025
- Rani Therapeutics Holdings, Inc. 13F 2024RANI 13F 2024: institutional holdings for fiscal 2024
- Rani Therapeutics Holdings, Inc. 13F 2023RANI 13F 2023: institutional holdings for fiscal 2023
- Rani Therapeutics Holdings, Inc. 13F 2022RANI 13F 2022: institutional holdings for fiscal 2022
More companies